$KDOZF

Williams Tryon M purchased $294 of KDOZF

Williams Tryon M (Chairman) purchased 2,500 shares of KIDOZ INC. (KDOZF) at $0.12 on 2026-07-16.

Original reporting
SEC EDGAR · Williams Tryon M
Published Jul 22, 2026, 1:25 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 22, 2026, 1:33 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$KDOZF
Neutral
medium confidence
Mentioned
$KDOZF
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$KDOZFNeutralLow
01

Why it matters

The newest fact is the chairman’s open-market purchase of 2,500 shares at $0.1175, with no pre-arranged 10b5-1 plan indicated.

02

Market read

Traders may note the insider buy as a mild sentiment input, but the disclosed value is small and lacks fundamental follow-through in the text.

03

What to watch

The article does not state whether the purchase was part of any broader accumulation strategy beyond the single transaction, and the company’s OTC liquidity can make the filing’s signal noisy.

Relevance 4/10Novelty 5/10Timing: latest Form 4 filed 2026-07-21, covering a 2026-07-16 purchase

Background

The article is an SEC Form 4 insider transaction disclosure for KIDOZ Inc. (KDOZF).

Company-level read

Ticker impact

$KDOZFNeutralMedium confidence
Context

Form 4 shows Williams Tryon M, KIDOZ Inc. chairman, bought 2,500 shares at $0.1175 on 2026-07-16, totaling $293.75.

Expected impact

Low likelihood of near-term price impact; any effect is more sentiment than fundamentals.

Evidence & confidence

The filing is primary-source and confirms an insider buy, but the dollar value is very small and there is no accompanying operational or financial catalyst.

Market effects

No sector read-across; this is a single-company insider transaction in an OTC/illiquid name.

None indicated.

None indicated.

Counterpoint

Insider buys in tiny size can be routine liquidity or personal allocation decisions and may not signal improved fundamentals.

Key entities

  • KIDOZ INC.

    OTC issuer referenced in the Form 4 insider transaction.

  • Williams Tryon M

    Chairman and officer/director/10% owner who executed the purchase.

Related articles